<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01893476</url>
  </required_header>
  <id_info>
    <org_study_id>258837</org_study_id>
    <nct_id>NCT01893476</nct_id>
  </id_info>
  <brief_title>A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management</brief_title>
  <acronym>TICD-COPD</acronym>
  <official_title>Tailored Implementation for Chronic Diseases.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Universtity of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Universtity of Lodz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Chronic Obstructive Pulmonary Disease (COPD) remains a major health problem,
      which is strongly related to smoking. Despite publication of guidelines on the prevention and
      treatment of COPD, not all COPD patients receive the best available healthcare. Investigators
      developed a tailored implementation strategy for improving primary care physicians' adherence
      to COPD management guidelines. The primary aim of the presented trial is to evaluate the
      effects of this strategy on physician's performance. The secondary aim is to examine the
      validity of the tailoring of implementation interventions.

      Primary Trial Hypothesis: To study if the rate of adherence to the COPD guideline over a 1
      year will increase among participants assigned to the intervention group in comparison to
      those assigned to the control group?

      Methods/Design: A two-arm pragmatic cluster randomized trial is planned. A total of 540
      patients with diagnosed COPD will be included from 18 general practices in Poland. A tailored
      implementation program will be offered to general practitioners. Participating physicians in
      the intervention practices (n=18) will receive training to provide brief anti-smoking
      counselling. An additional form containing COPD severity scale will be inserted into
      patient's medical records. The checklist with key information about the disease and its
      management while consulting a patient with COPD will be provided to practitioners.
      Investigators will provide practices with training inhaler devices for general practitioners
      (GPs) to teach patients in correct use of each device and to note this education/training in
      patient's medical records. The control practices will provide usual care.

      Discussion: The results of this trial will be directly applicable to primary care in Poland
      and add to the growing body of evidence on interventions to improve chronic illness care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic Obstructive Pulmonary Disease (COPD) remains a major health problem. Worldwide it has
      been ranked as the sixth leading cause of death for both genders. In 2020 COPD is projected
      to rank fifth worldwide in burden of disease. It is also projected to be the fourth leading
      cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes
      in many countries. The national survey conducted in Poland in 2007 indicated that 34% of men
      smoked daily, 2% were occasional smokers, 19% were former smokers and 45% never smoked. In
      women, these percentages were, respectively, 23%, 3%, 10% and 64%. Although COPD has received
      increasing attention from the medical community in some countries in recent years, it is
      still relatively unknown or ignored by the public as well as many healthcare providers and
      government officials.

      Epidemiological studies of COPD on a representative sample have not been performed in Poland,
      but estimates from smaller suggested a relatively high prevalence. Studies which covered a
      selected geographical population found that signs and symptoms of COPD are seen in about 10%
      of patients over 40 years old. Studies in big cities in Poland showed a 9,8% prevalence of
      COPD in populations between 41 and 72 years old. These data are similar to European data,
      describing prevalence rates of 4-11% of COPD in adults in Europe. The absolute number of
      people suffering from COPD in Poland is estimated on about 2 million. This places COPD as the
      third most frequent - concerning frequency - chronic illness, and it is the fourth most
      common cause of death in Poland.

      In Poland, many guidelines on COPD are used, some of which are national and some are
      international. There is no guideline in Poland which is designed for primary care.

      Implementation of interventions directed on health professionals knowledge programme can
      change the professionals behavior. In this study the support strategy is applied to improve
      implementation process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of selected patients receiving anti-tabacco counseling recorded by the GPs in the labeled patients' medical records.</measure>
    <time_frame>1 year</time_frame>
    <description>Brief anti-smoking counseling will be provided for GPs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health outcomes in patients' medical records.</measure>
    <time_frame>1 year</time_frame>
    <description>Investigators will review COPD patients' medical records to measure health outcomes such as smoking status change, quantity of and adherence to medication, change in modified Medical Research Council (mMRC) scale and number of exacerbations in the past and over the study period.
Also, investigators will consider utilization of the Chronic Respiratory Questionnaire (CRQ).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence to the selected guidelines by GPs in primary care settings.</measure>
    <time_frame>1 year</time_frame>
    <description>The percentage of GPs adhering to the selected guidelines in primary care settings.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">540</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In this arm, practitioners will provide usual care for COPD patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>adherence to guideline</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implementation educational programme: guideline adherences. The results of this trial will be directly applicable to primary care settings. Should the interventions delivered at the level of the GP practice be found to be effective in improving patients' quality of life then the findings would have a wider application.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implementation educational programme</intervention_name>
    <description>Implementation educational programme will include: brief anti-smoking counseling, mMRC scale, checklist, training patient on correct use of inhaling. Participating physicians will receive training in brief anti-smoking counselling and will be asked to record information about. Additional form containing the mMRC dyspnoea scale will be inserted into patients' medical records. We will elaborate a checklist for practitioners with information about what should be done while consulting a patient with COPD. Investigators will provide practices with training inhaler and train staff. Practitioners will be asked to teach patients in correct use of each device. Practitioners will be asked to put this information to the patient's medical records.</description>
    <arm_group_label>adherence to guideline</arm_group_label>
    <other_name>implementation programme</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with diagnosed COPD via the medical records with code J44

        Exclusion Criteria:

          -  terminal illness

          -  cognitive impairments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maciej Godycki-Cwirko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Lodz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Lodz</name>
      <address>
        <city>Lodz</city>
        <zip>90-419</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://www.ticd.umed.lodz.pl/</url>
    <description>Website of TICD project.</description>
  </link>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2013</study_first_submitted>
  <study_first_submitted_qc>July 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2013</study_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Universtity of Lodz</investigator_affiliation>
    <investigator_full_name>dr Maciej Godycki-Ä†wirko</investigator_full_name>
    <investigator_title>PhD, MD</investigator_title>
  </responsible_party>
  <keyword>chronic obstructive pulmonary disease</keyword>
  <keyword>implementation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

